Trial intelligence / Profile preview

Serratiopeptidase After Surgical Removal of Mesioangular Mandibular Third Molars

NCT07543146Completed

Sponsor
Sharif Medical Research Center
Start
Jun 2025
Primary completion
Sep 2025
Modality
Replacement Enzymes
Countries
1
01

Overview

Randomised trial of serrapeptase in trismus (2 arms), sponsored by Sharif Medical Research Center. Primary endpoint: Postoperative Facial Swelling at Day 7. Started Jun 2025; status: completed.

02

Drugs

serrapeptase
03

Conditions

trismus

Beyond the preview

Go deeper on NCT07543146.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07543146.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call